Zongertinib is approved for unresectable or metastatic nonsquamous NSCLC with HER2 TKD mutations, following systemic therapy and confirmed by an FDA-approved test. The Oncomine Dx Target Test is ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
[{"search_type":"general-inventory-search","vehicle_array":[{"trim":"EX-L","make":"Honda","cat":"sedan_midsize","year":"2009","seller_type":"dealership","customer_id ...